DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can radiation and an antibiotic make CAR-T therapy safer and more effective?
Disease control Not yet recruitingThis early-stage trial tests whether giving radiation therapy and the antibiotic vancomycin before standard CAR-T cell treatment is safe and doable for people with large B-cell lymphoma. About 14 adults whose lymphoma has come back or not responded to treatment will take part. Th…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New antibody therapy could boost transplant success in tough lymphoma
Disease control Not yet recruitingThis study tests a drug called glofitamab in 40 adults with aggressive B-cell lymphoma that did not respond to or came back after initial treatment. Participants are eligible for a stem cell transplant. Glofitamab is an antibody that helps the immune system attack lymphoma cells.…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE2 • Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated May 11, 2026 20:51 UTC